Structural and Hemodynamic Changes Associated with Physiologic Heart Hypertrophy of Pregnancy are Reversed Postpartum  by Umar, Soban et al.
Sunday, February 26, 2012 139a694-Pos Board B480
Variable T-Tubule Density and Organization in Rat Atrial
Cardiomyocytes
Michael Frisk1,2, Ole M. Sejersted1,2, William E. Louch1,2.
1Center for Heart Failure Research, University of Oslo, Oslo, Norway,
2Institute for Experimental Medical Research, Oslo University Hospital,
Ulleva˚l, Oslo, Norway.
T-tubules are invaginations in the cellular membrane of the myocyte. In ven-
tricular cardiomyocytes initiation of excitation-contraction coupling is highly
localized near the t-tubules, which span the cell in a predominantly transverse
orientation. While t-tubules have traditionally been thought to be virtually ab-
sent from atrial cells, recent data indicate that a fairly substantial network is
present in the atria of large mammals. We presently compared the t-tubule net-
work of atrial and ventricular cardiomyocytes in 6 week-old Wistar rats. Atrial
myocytes were isolated by dicing and agitating tissue in the presence of colla-
genase, and ventricular cells were isolated by Langendorf perfusion. Cell mem-
brane and t-tubules were stained with di-8-ANEPPS and imaged by confocal
microscopy. 100% of ventricular and 37% of atrial cardiomyocytes possessed
a measurable t-tubular density (defined as occupying >5% of the cytosolic
lumen). In the tubulated atrial cells, t-tubular density was similar to that ob-
served in ventricular myocytes (% cross-sectional area = 16% in atrial vs.
17% in ventricular cardiomyocytes, P=0.76). Surprisingly, 10% of atrial myo-
cytes exhibited an organized, largely transverse structure. Power spectral anal-
ysis revealed that this organization was somewhat less homogeneous than that
observed in ventricular cells, as atrial myocytes exhibited a higher proportion
of longitudinal elements (ratio of peak power to between-peak power = 3.15
in atrial vs. 5.13 in ventricular cells, P=0.02). Neither density nor organization
of t-tubules was correlated to atrial cardiomyocyte size. Thus, in contrast to
several previous reports, a significant proportion of rat atrial cardiomyocytes
possess a t-tubule network which is as extensive as that observed in ventricular
cells. Furthermore, in a minority of atrial cardiomyocytes (approximately 10%)
the t-tubular network is well organized into a predominately transverse
structure.
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Altered Action Potential Heterogeneity in Hypertrophic Right Ventricles
of Rats
Matthew E.L. Hardy1, Olivier Bernus2, Ed White1.
1University of Leeds, Leeds, United Kingdom, 2Inserm U-1045, Universite
de Bordeaux, Bordeaux, France.
Hypertrophy of the myocardium causes electrophysiological remodeling and
changes in action potential duration (APD). The right ventricle (RV) becomes
hypertrophied and fails under conditions of pulmonary artery hypertension
(PAH). The current study evaluated changes in APD heterogeneity in a rodent
model of PAH.
Male Wistar rats were given a single i.p. injection of monocrotaline (60 mg/kg)
or an equivalent volume of saline. When clinical symptoms of heart failure
became apparent (3-4 weeks later) animals were euthanized and the hearts ex-
cised. Electrical activity was optically monitored from the epicardial surface of
both ventricles in intact hearts using di-4-ANEPPS. The myocardium was stim-
ulated at basic cycle lengths (BCLs) between 80-160 ms. APD at 80% repolar-
ization (APD80) was calculated at the mid-LV, mid-RV and right ventricular
outflow tract (RVOT) regions.
At 160 ms BCL, APD80 was significantly longer in hypertrophied compared to
sham in both RV regions however 8/9 hypertrophied hearts had a longer APD80
in the RVOT vs. mid-RV, whilst in 11/11 sham hearts the APD80 was shorter in
the RVOT. The changes in APD between the two RV regions were significantly
different (MCT RVOT - mid-RV þ6.6 5 2.6 ms vs. Sham RVOT - mid-RV
6.8 5 1.3 ms, p<0.0001 unpaired Student’s t-test). APD restitution curves
were significantly steeper in the mid-RV and RVOT of hypertrophied hearts
than the mid-LV or mid-LV, mid-RV and RVOT of sham hearts.
These data show that electrical remodeling in monocrotaline treated RV was
heterogenous. These regionally dependant changes in APD may contribute to
the pro-arrhythmic state of hypertensive and hypertrophic RVs.
Supported by the MRC.
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Conditional SERCA2 Ablation Impairs Systolic and Diastolic Perfor-
mance of Isolated Perfused Hearts
Frazer I. Heinis1, Kristin B. Andersson2, Geir Christensen2,
Joseph M. Metzger1.
1University of Minnesota, Minneapolis, MN, USA, 2University of Oslo,
Oslo, Norway.
Highly orchestrated contraction and relaxation of the myocardium depends
on rapid release and reuptake of Ca2þ from the sarcoplasmic reticulum (SR).SERCA2a, a cardiac SR Ca2þ-ATPase, is a major contributor to re-
sequestration of Ca2þ and shows reduced expression with age and in heart fail-
ure. Conditional deletion of the Serca2 gene from the hearts of fl/fl mice results
in progressive diastolic dysfunction, heart failure, and death over a period of
two months. To gain insight into the interplay between Ca2þ-mishandling
and the evolution of cardiac pump failure we studied mice at 1 and 4 weeks fol-
lowing cardiac specific cre-mediated deletion of the Serca2 gene from fl/fl
mice. At each time point, isolated hearts were subjected to paced stimulation
across a broad frequency range, followed by ischemia/reperfusion injury. At
both 1 and 4 weeks, SERCA2a loss resulted in profound contractile deficits
and diastolic impairment relative to normal hearts. However, there was no
difference in the relative performance of normal and KO hearts following
ischemia/reperfusion injury, suggesting that depleting SR Ca2þ is not protec-
tive from ischemia. Curiously, 1 week after Serca2 deletion, when 15-20%
of baseline SERCA2a protein remains, diastolic performance in response to
stepped increases in pacing frequency was impaired to a similar degree as in
4-week KO hearts containing <5% original protein levels. We are further in-
vestigating the consequences of SERCA2a loss shortly after gene deletion, at
times less than one week after knockout, to construct a detailed dose-
response relationship between titrated changes in SR Ca2þ handling and con-
tractile function.
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Elevated Plasma Oxidized Lipids in Severe Pulmonary Hypertension are
Fully Restored by Estrogen Therapy
Soban Umar, Mansour Eghbali, Katharina Volz, Denise Mai,
Mansoureh Eghbali.
Univ of California, Los Angeles, Los Angeles, CA, USA.
Recently we reported that estrogen (E2) rescues pre-existing severe pulmonary
hypertension (PH). PH is associated with pulmonary vascular remodelling.
Vascular disorders result from complex interactions between oxidized-
lipoproteins, monocytes/macrophages, injured endothelium and smooth muscle
cells. Biological oxidation products of arachidonic acid, including prostaglan-
dins (PGs), thromboxanes (TXs), hydroxyeicosatetraenoic acids (HETEs) and
hydroxyoctadecadienoic acids (HODEs) play an important role in the patho-
genesis of atherosclerosis, yet their role in PH is not fully known. Here we
investigated whether PH is associated with increased plasma levels of
oxidized-lipids, and if E2 can restore their levels. To induce PH, rats received
monocrotaline (MCT, 60mg/kg, s.c.). Severe PH was established 21-days after
MCT (PH, n=8). E2 (42.5ug/kg/day, s.c., n=6) was given from day-21 to 30.
Saline treated rats served as control (CTRL, n=7). Cardiac catheterization was
performed terminally to record RV-pressure (RVP). Plasma HODEs, HETEs,
TXs and PGs were determined by mass-spectrometry. p<0.05 was considered
significant. Values were mean5SE. Rats developed severe PH [RVP=6852
vs. 3152 mmHg in CTRL, p<0.01). E2 rescued PH (RVP=3851 mmHg,
p<0.01 vs. PH). PH was associated with increased plasma levels (ng/ml of
plasma) of 9-HODE (22175381 vs. 9495255 in CTRL, p<0.05) and
13-HODE (43475439 vs. 18715609 in CTRL, p<0.05). E2 reversed PH-
induced increase in HODEs (9-HODE=9765259; 13-HODE=24695531; all
p<0.05 vs. PH). PH led to significantly elevated plasma 5-HETE (938577 vs.
663515), 12-HETE (97205972 vs. 66335522) and 15-HETE (818562 vs.
53457; all p<0.05 vs. CTRL). E2 fully reversed the increase in HETEs
(5-HETE=708537; 12-HETE=69815248; 15-HETE=622550; p<0.05 vs.
PH). PH also led to elevated plasma TXB2 (3.550.2 vs. 2.850.1), PGD2
(98511 vs. 3557) and PGE2 (2751 vs. 1352; all p<0.05 vs. CTRL) and
E2 restored their levels (TXB2=2.650.2; PGD2=54510; PGE2=1952; all
p<0.05). In conclusion, severe PH is associated with increased plasma levels
of oxidized lipids that are fully restored by E2.
698-Pos Board B484
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Soban Umar, Andrea Iorga, Rangarajan D. Nadadur, Marjan Amjedi,
Mansour Eghbali, Ray Chui, Humann Matori, Mansoureh Eghbali.
Univ of California, Los Angeles, Los Angeles, CA, USA.
We have previously characterized pregnancy-induced physiological heart
hypertrophy. Pregnancy is associated with ventricular hypertrophy and short-
term systolic and diastolic dysfunction due to volume-overload. Here we inves-
tigated whether cardiac structural and hemodynamic changes associated
with pregnancy are reversed postpartum. Female mice (3-4month, C57BL/6)
were used in non-pregnant diestrus-stage (NP), late pregnant (LP), 1-day
postpartum (PP1), or 7-days PP (PP7). Echocardiography and cardiac-
catheterisation were performed to monitor cardiac-hemodynamics. RT-PCR
was performed to determine vascular endothelial growth factor (VEGF) and
matrix metalloproteinase-2 (MMP2) transcripts. Trichrome staining for cardiac
140a Sunday, February 26, 2012fibrosis and CD31 immunostaining for cardiac angiogenesis were performed. A
p<0.05 was considered significant. Values were mean5SE. LP was associated
with heart hypertrophy (p<0.05 vs. NP) that was reversed 7-days PP (heart
weight: NP=12053, LP= 16352, PP1= 14552, PP7= 11751 mg). Con-
versely, heart weight/body weight (hw/bw) ratio was decreased in LP
(p<0.05 vs. NP) that was reversed in PP1 (hw/bw: NP=5.950.1, LP=
4.550.1, PP1= 5.650.1). LV ejection fraction was reduced in LP (p<0.05
vs. NP) and was also restored at PP1 (NP=7454, LP= 5751, PP1=
7351%). Cardiac angiogenesis was significantly increased in LP (p<0.001
vs. NP), and was fully restored in PP7 (p<0.001 vs. LP) (Capillary density:
NP=0.9550.01, LP=1.2550.02, PP7=0.9850.01 capillaries/myocyte). Simi-
larly, VEGF was upregulated in LP, and was restored in PP7 (NP=150.1,
LP=1.4 50.1, PP7=0.8350.1). There was no increase in cardiac fibrosis
in pregnancy-induced heart hypertrophy. Transcript levels of extracellular
matrix (ECM) degrading enzyme MMP2 were downregulated in LP (p<0.05
vs. NP) and were restored at 7-days PP (NP=150.01, LP=0.4750.03,
PP7=0.7050.1). In conclusion, pregnancy-induced heart hypertrophy is asso-
ciated with increased cardiac angiogenesis, lack of fibrosis, decreased MMP2
and decreased diastolic function of the heart that are reversed postpartum.
We speculate that physiologic heart hypertrophy of pregnancy has minimal
cardiac ECM remodeling.
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Apolipoprotein-A1Mimetic Peptide 4F Rescues Severe Pulmonary Hyper-
tension in Rats and Inhibits Human Pulmonary Artery Smooth Muscle
Cell Proliferation In Vitro
Soban Umar, Rangarajan D. Nadadur, Katharina S. Volz, Reza Foroughi,
Mansoureh Eghbali.
Univ of California, Los Angeles, Los Angeles, CA, USA.
Pulmonary hypertension (PH) is a characterized by arterial obstruction result-
ing from proliferation of pulmonary artery smooth muscle and endothelial cells.
Genetic deletion of apolipoprotein-A1 increases airway hyperresponsiveness,
inflammation, and collagen deposition in the lung. Apolipoprotein-A1 mimetic
peptide 4F protects endothelial function, causes vasodilation, decreases inflam-
mation and oxidative stress in lungs, yet its role in treating PH and right ven-
tricular (RV) dysfunction is not known. We hypothesized that 4F may rescue
pre-existing severe PH. We also investigate the effects of 4F on human pulmo-
nary artery smooth muscle cell (hPASMC) proliferation in vitro as a possible
mechanism of rescue by 4F. Twenty three rats were randomly divided into
4-groups. PH was induced by monocrotaline (MCT, 60mg/kg, s.c.). Severe
PH was well-established at day-21 (PH, n=6) that progressed to RV failure
(RVF, n=6) by day-30. One MCT-group was treated with 4F (50mg/kg/day,
s.c., n=6) from day-21 to 30. Saline-treated rats served as control (CTRL,
n=5). Serial echocardiography was performed to monitor cardiopulmonary he-
modynamics. Cardiac catheterization was performed terminally to record RV-
pressure (RVP). hPASMCs proliferation was assessed by MTT-assay. p<0.05
was considered significant. Values were mean5SE. Rats developed severe
PH 21-days after MCT (RVP=67.1251 vs. 29.851 mmHg in CTRL, RV/
LVþIVS= 0.6550.05 vs. 0.2350.02, RV-ejection fraction (RVEF)= 4051
vs. 6551%, all p<0.05 vs. CTRL), which progressed to RVF by day-30
[RVP=7451; RV/(LVþIVS)=0.6850.05; RVEF=28.651%, p<0.05 for all
vs. CTRL]. 4F-therapy from day-21 to 30 resulted in rescue of PH
(RVP=4753 mmHg, RV/LVþIVS= 0.3850.02, RVEF= 51.753%, p<0.05
vs. PH and RVF). 4F also inhibited hPASMC proliferation (~60% inhibition
at 100ng 4F/ml medium, p<0.05). In conclusion, 4F rescues pre-existing severe
PH and RV-dysfunction. Inhibition of PASMC proliferation may be one of the
key mechanisms in this rescue.
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Genistein Therapy Reverses Lung Inflammation and Fibrosis during
Severe Pulmonary Hypertension through Estrogen Receptor Beta
Rangarajan Nadadur, Soban Umar, Humann Matori, Andrea Iorga,
Denise Mai, Marjan Amjedi, Mansoureh Eghbali.
UCLA, Los Angeles, CA, USA.
Pulmonary Hypertension (PH) is a disease of increasing pulmonary arterial
pressure characterized by extensive lung inflammation and fibrosis. We have
previously shown that Genistein, a soy isoflavone, can rescue severe PH. Since
Genistein is a selective Estrogen Receptor Beta agonist, here we examined
whether Genistein can reverse fibrosis and inflammation induced by PH via
an Estrogen Receptor Beta dependent mechanism. PH was established by treat-
ing male rats with monocrotaline (MCT, 60mg/kg, s.c.). At day 21 when severe
PH was established, rats were treated with 10 day Genistein therapy (Gen
group), Genistein therapy in the presence of selective Estrogen Receptor
b antagonist PHTPP (GenþPHTPP group), or were left untreated to develop
right ventricular failure (RVF group). RVF animals developed severe pulmo-nary hypertension (RVP=72.9651.39mmHg vs 31.1550.56 mmHg in
CTRL; RVEF=28.7650.79% vs 66.2251.40% in CTRL, all p<.05). Genis-
tein therapy restored these abnormalities (RVEF=65.6751.08%, RVP ¼
43.3454.08 mmHg, p<0.05 vs RVF). Interestingly, in the presence of
Estrogen Receptor Beta antagonist PHTPP, Genistein failed to rescue these
animals (RVP=61.2254.40, RVEF=42.2752.7%, p=n.s. vs RVF). Masson’s
Trichrome staining revealed extensive lung fibrosis in RVF group, which
was also restored with Gen therapy. Again, GenþPHTPP group showed no
reversal of pulmonary fibrosis. Immunoperoxidase staining showed an increase
in ED-1 positive cells in the lung of RVF-group indicating increased inflamma-
tion. This change was reversed entirely by Genistein therapy. RT PCR also
revealed that pro-inflammatory molecules TNFa and IL-1b were both elevated
more than 2-fold in the lung of RVF animals and reversed with Genistein
therapy (all p<0.05). Interestingly, GenþPHTPP animals still showed signifi-
cantly elevated ED-1 positive cells in the lung as well as elevated TNFa and
IL1b (all p=n.s. vs RVF). These results suggest that genistein induced reversal
of lung inflammation and fibrosis during pulmonary hypertension is mediated
through Estrogen Receptor b.
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Estrogen Treatment Reverses Heart Failure-Induced Cardiac Fibrosis and
Inflammation
Andrea Iorga, Rangarajan Nadadur, Katharina Volz, Jingyuan Li,
Mansoureh Eghbali.
UCLA, Los Angeles, CA, USA.
Heart failure is generally characterized by increased fibrosis and inflammation,
which lead to functional and contractile defects. Recently we discovered that
estrogen (E2) therapy can rescue advanced heart failure (HF) induced by pres-
sure overload in mice by restoring left ventricular (LV) pressure and function.
Here, we investigate the effects of E2 on reversing the adverse remodeling of
the LV occurring during HF. Trans-aortic constriction procedure was used
to induce HF. Once the ejection fraction reached ~30%, one group of
mice was sacrificed and the other group was treated with E2 (30 mg/kg/day)
for 10 days. In vitro, co-cultured neonatal rat ventricular myocytes and
fibroblasts were treated with angiotensin II (AngII) in the presence or absence
of E2. Quantitative real-time PCR showed that the transcript levels of the pro-
fibrotic markers collagen I, TGFb, fibrosin 1 (FBRS) and lysil oxidase (LOX)
were significantly upregulated in HF (from 1.0050.16 to 1.8350.11for
collagen 1, 1.0050.86 to 4.3350.59 for TGFb, 1.0050.52 to 3.6150.22
for FBRS and 1.0050.33 to 2.8850.32 for LOX) and were reduced with E2
treatment to levels similar to CTRL. In vitro studies validated our in vivo find-
ings, as E2 also restored AngII-induced upregulation of LOX and TGFb from
6.8750.26 in AngII to 2.8051.5 in AngIIþE2 and 3.3050.25 to 1.5950.21
in AngIIþE2, respectively (values normalized to CTRL). Furthermore, the pro-
inflammatory interleukins IL-1b and IL-6 were upregulated from 1.0050.19 to
1.9050.09 and 1.0050.30 to 5.2950.77 in HF, respectively, and reversed to
CTRL levels with E2 therapy. The anti-inflammatory interleukin IL-10 was
downregulated from 1.0050.17 to 0.4950.03 in HF and reversed to
0.6750.09 with E2 treatment. This data strongly suggests that one of the mech-
anisms for the beneficial action of estrogen on left ventricular heart failure is
through reversal of inflammation and fibrosis.
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Estrogen Directly Reverses Cardiac Remodeling Associated with Pulmo-
nary Hypertension Induced Right Ventricular Failure
Rangarajan Nadadur, Soban Umar, Andrea Iorga, Humann Matori,
Rod Partow-Navid, Mansoureh Eghbali.
UCLA, Los Angeles, CA, USA.
Pulmonary hypertension (PH) leads to right-ventricular hypertrophy and failure
(RVF). RVF involves adverse remodeling of the ventricular extracellular
matrix (ECM). Recently we found that estrogen (E2) rescues PH-induced
RVF. Here we explore whether the rapid restoration of RV function by E2 ther-
apy during PH-induced RVF is in part due to a direct effect of E2 on the adverse
ECM remodeling of the RV. In vivo, rats were injected with monocrotaline. At
day 21, when PH had established, rats either received E2 (E2-group) for 10
days or were left untreated to develop RVF (RVF-group). In vitro, co-
cultured neonatal rat ventricular myocytes and fibroblasts were treated with
Angiotensin II in the presence or absence of E2 (AngII and AngIIþE2 resp.).
In vivo, E2 reversed RV fibrosis (4.0650.52% in CTRL, 3353.2 in RVF,
5.6650.33% in E2 group, all P<.05). In vitro, E2 similarly inhibited AngII in-
duced increase in Collagen I transcript in cultured myocytes and fibroblasts
(1.4950.04 in AngII, 0.7550.04 in AngIIþE2, normalized to CTRL,
p<.05). In vivo, E2 reversed PH induced increases of ECM remodeling en-
zymes OPN, ADAM15 and ADAM17 in the RV (9.3352.07 in RVF,
0.4550.16 in E2 for OPN; 2.1350.19 in RVF, 0.4750.07 in E2 for
